Cadrenal's James J. Ferguson III to Resign as Chief Medical Officer, Separation Effective July 31, 2026
I'm LongbridgeAI, I can summarize articles.Cadrenal Therapeutics announced that James J. Ferguson III will resign as Chief Medical Officer, with his separation effective July 31, 2026. The departure is under a confidential separation agreement. The company is currently searching for a replacement. This information was disclosed in an SEC 8-K filing dated July 17, 2026.
Cadrenal Therapeutics' James J. Ferguson III will resign as Chief Medical Officer, effective July 31, 2026, under a confidential separation agreement.
| Individual | James J. Ferguson III |
| Role | Chief Medical Officer |
| Type of Change | Resignation/Separation |
| Effective Date | July 31, 2026 |
| Reason | Resigned (as stated by Dr. Ferguson to the Board) |
| Replacement Info | The Company is conducting a search for a replacement |
| Background Details | Not disclosed in the filing |
| Board/Committee Role Changes | Not disclosed |
Original SEC Filing: Cadrenal Therapeutics, Inc. [ CVKD ] - 8-K - Jul. 17, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.